Mashup Score: 11 Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction - American College of Cardiology - 3 year(s) ago Dharam J. Kumbhani, MD, SM, FACC Source: American College of Cardiology Categories: Cardiology News and Journals, Latest Headlines Tweet Tweets with this article ACCinTouch The #PARADISEMI trial showed that sacubitril/valsartan did not reduce the primary endpoint in a contemporary enriched #cvAMI population, compared with #ramipril. More: https://t.co/LVdmJI1Wv2 #ACC21
The #PARADISEMI trial showed that sacubitril/valsartan did not reduce the primary endpoint in a contemporary enriched #cvAMI population, compared with #ramipril. More: https://t.co/LVdmJI1Wv2 #ACC21